Sparta Biopharma Announces US Commercial Availability of BioEnthesis™ for Rotator Cuff Repair
Sparta Biopharma Announces US Commercial Availability of BioEnthesis™ for Rotator Cuff Repair News provided by Share this article Share this article DURHAM, N.C. and MADISON, N.J., March 9, 2021 /PRNewswire/ -- Sparta Biopharma, Inc., a privately-held company, developing osteobiologics for sports medicine announces the availability of BioEnthesis TM, the first-of-its-kind allograft that has both mineralized and demineralized layers which provide the requisite properties for healing and repair within the rotator cuff. According to the Healthcare Cost and Utilization Project, there are mor...
Source: prnewswire.com